Shanghai Junshi Biosciences Co., Ltd. (SHJBF)

SHJBF Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,522	2,502	3,788	5,997	3,507	3,385
Short-Term Investments	-	-	-	17.93	-	-
Trading Asset Securities	500.64	430.51	-	-	-	0.02
Cash & Short-Term Investments	3,022	2,933	3,788	6,015	3,507	3,385
Cash Growth	-33.71%	-22.58%	-37.02%	71.53%	3.59%	177.26%
Accounts Receivable	398.63	509.82	483.23	232.73	1,301	664.44
Other Receivables	15.94	36.44	374.01	78.81	28.05	22.84
Receivables	414.57	546.26	857.23	314.25	1,329	687.28
Inventory	589.12	584.47	538.05	599.02	484.6	343.43
Prepaid Expenses	-	-	-	239.82	-	-
Other Current Assets	214.32	220.38	387.59	36.94	524.79	283
Total Current Assets	4,240	4,284	5,571	7,205	5,845	4,699
Property, Plant & Equipment	4,204	4,195	3,809	3,278	2,801	2,377
Long-Term Investments	1,318	1,226	1,133	1,292	1,485	422.9
Other Intangible Assets	514.19	521.41	546.96	98.91	264.98	162.09
Long-Term Deferred Tax Assets	94.05	87.05	103.4	228.43	88.55	26.11
Long-Term Deferred Charges	-	6.12	12.6	-	27.79	13.24
Other Long-Term Assets	526.39	461.94	167.14	473.39	522.34	297.73
Total Assets	10,897	10,782	11,343	12,576	11,035	7,997
Accounts Payable	1,059	115.9	125.19	370.23	63.17	55.69
Accrued Expenses	261.05	901.44	1,046	917.21	1,603	826.28
Short-Term Debt	943.93	678.11	452.44	391.75	-	21.23
Current Portion of Long-Term Debt	-	216.5	86.96	-	10.6	231.11
Current Portion of Leases	-	30.29	35.93	43.66	34.47	25.22
Current Income Taxes Payable	23.8	12.41	17.98	-	63.08	-
Current Unearned Revenue	118.27	8.17	146.3	0.44	45.8	43.14
Other Current Liabilities	638.68	531.11	527.92	50.96	181.59	269.79
Total Current Liabilities	3,045	2,494	2,438	1,774	2,001	1,472
Long-Term Debt	1,769	1,980	1,196	839.58	490	542.22
Long-Term Leases	68.3	26.31	17.45	46.59	93.13	30.99
Long-Term Unearned Revenue	177.91	181.91	183.46	121.62	122.46	122.65
Other Long-Term Liabilities	167.61	168	187.15	-	11.5	1.28
Total Liabilities	5,228	4,850	4,022	2,782	2,719	2,170
Common Stock	985.69	985.69	985.69	982.87	910.76	872.5
Additional Paid-In Capital	-	15,407	15,395	-	11,423	8,632
Retained Earnings	-10,576	-10,341	-9,060	-	-4,389	-3,668
Treasury Stock	-30.89	-30.89	-26.89	-	-	-
Comprehensive Income & Other	15,241	-159.94	-142.07	8,519	0.21	-9.39
Total Common Equity	5,620	5,860	7,151	9,501	7,945	5,828
Minority Interest	48.92	71.71	169.39	292.83	371.28	-0
Shareholders' Equity	5,669	5,932	7,321	9,794	8,316	5,828
Total Liabilities & Equity	10,897	10,782	11,343	12,576	11,035	7,997
Total Debt	2,782	2,931	1,789	1,322	628.19	850.78
Net Cash (Debt)	240.75	1.82	2,000	4,693	2,878	2,534
Net Cash Growth	-84.26%	-99.91%	-57.39%	63.05%	13.58%	608.08%
Net Cash Per Share	0.24	0.00	2.03	5.12	3.23	3.08
Filing Date Shares Outstanding	984.87	984.87	985.01	982.87	910.76	872.5
Total Common Shares Outstanding	984.87	984.87	985.01	982.87	910.76	872.5
Working Capital	1,196	1,790	3,133	5,431	3,843	3,226
Book Value Per Share	5.71	5.95	7.26	9.67	8.72	6.68
Tangible Book Value	5,106	5,339	6,604	9,403	7,680	5,666
Tangible Book Value Per Share	5.18	5.42	6.70	9.57	8.43	6.49
Buildings	-	1,379	1,419	-	891.83	880.3
Machinery	-	2,022	1,921	1,522	1,419	1,247
Construction In Progress	-	1,859	1,325	1,048	801.93	415.55
Leasehold Improvements	-	-	-	65.57	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.